The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global DNA & RNA Oligonucleotides Market Research Report 2025
Synopsis
An oligonucleotide is a short chain of DNA or RNA molecules. It is used in molecular biology and medicine as a probe to screen for diseases, viral infections, and to identify genes in molecular biology experiments. It is also used as a primer in a type of DNA sequencing. Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences.
The global DNA & RNA Oligonucleotides market was valued at US$ 1254 million in 2023 and is anticipated to reach US$ 1477 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
North American market for DNA & RNA Oligonucleotides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for DNA & RNA Oligonucleotides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for DNA & RNA Oligonucleotides in Hospitals and Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of DNA & RNA Oligonucleotides include Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences and Macrogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for DNA & RNA Oligonucleotides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA & RNA Oligonucleotides.
Report Scope
The DNA & RNA Oligonucleotides market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global DNA & RNA Oligonucleotides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA & RNA Oligonucleotides companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Genotypic Technology
Dna Link
Segment by Type
DNA Oligonucleotides
RNA Oligonucleotides
Segment by Application
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of DNA & RNA Oligonucleotides companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
An oligonucleotide is a short chain of DNA or RNA molecules. It is used in molecular biology and medicine as a probe to screen for diseases, viral infections, and to identify genes in molecular biology experiments. It is also used as a primer in a type of DNA sequencing. Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences.
The global DNA & RNA Oligonucleotides market was valued at US$ 1254 million in 2023 and is anticipated to reach US$ 1477 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
North American market for DNA & RNA Oligonucleotides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for DNA & RNA Oligonucleotides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for DNA & RNA Oligonucleotides in Hospitals and Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of DNA & RNA Oligonucleotides include Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences and Macrogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for DNA & RNA Oligonucleotides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA & RNA Oligonucleotides.
Report Scope
The DNA & RNA Oligonucleotides market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global DNA & RNA Oligonucleotides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA & RNA Oligonucleotides companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Genotypic Technology
Dna Link
Segment by Type
DNA Oligonucleotides
RNA Oligonucleotides
Segment by Application
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of DNA & RNA Oligonucleotides companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global DNA & RNA Oligonucleotides Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 DNA Oligonucleotides
1.2.3 RNA Oligonucleotides
1.3 Market by Application
1.3.1 Global DNA & RNA Oligonucleotides Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Academic & Research Organizations
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global DNA & RNA Oligonucleotides Market Perspective (2019-2030)
2.2 DNA & RNA Oligonucleotides Growth Trends by Region
2.2.1 Global DNA & RNA Oligonucleotides Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 DNA & RNA Oligonucleotides Historic Market Size by Region (2019-2024)
2.2.3 DNA & RNA Oligonucleotides Forecasted Market Size by Region (2025-2030)
2.3 DNA & RNA Oligonucleotides Market Dynamics
2.3.1 DNA & RNA Oligonucleotides Industry Trends
2.3.2 DNA & RNA Oligonucleotides Market Drivers
2.3.3 DNA & RNA Oligonucleotides Market Challenges
2.3.4 DNA & RNA Oligonucleotides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top DNA & RNA Oligonucleotides Players by Revenue
3.1.1 Global Top DNA & RNA Oligonucleotides Players by Revenue (2019-2024)
3.1.2 Global DNA & RNA Oligonucleotides Revenue Market Share by Players (2019-2024)
3.2 Global DNA & RNA Oligonucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by DNA & RNA Oligonucleotides Revenue
3.4 Global DNA & RNA Oligonucleotides Market Concentration Ratio
3.4.1 Global DNA & RNA Oligonucleotides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by DNA & RNA Oligonucleotides Revenue in 2023
3.5 DNA & RNA Oligonucleotides Key Players Head office and Area Served
3.6 Key Players DNA & RNA Oligonucleotides Product Solution and Service
3.7 Date of Enter into DNA & RNA Oligonucleotides Market
3.8 Mergers & Acquisitions, Expansion Plans
4 DNA & RNA Oligonucleotides Breakdown Data by Type
4.1 Global DNA & RNA Oligonucleotides Historic Market Size by Type (2019-2024)
4.2 Global DNA & RNA Oligonucleotides Forecasted Market Size by Type (2025-2030)
5 DNA & RNA Oligonucleotides Breakdown Data by Application
5.1 Global DNA & RNA Oligonucleotides Historic Market Size by Application (2019-2024)
5.2 Global DNA & RNA Oligonucleotides Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America DNA & RNA Oligonucleotides Market Size (2019-2030)
6.2 North America DNA & RNA Oligonucleotides Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America DNA & RNA Oligonucleotides Market Size by Country (2019-2024)
6.4 North America DNA & RNA Oligonucleotides Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe DNA & RNA Oligonucleotides Market Size (2019-2030)
7.2 Europe DNA & RNA Oligonucleotides Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe DNA & RNA Oligonucleotides Market Size by Country (2019-2024)
7.4 Europe DNA & RNA Oligonucleotides Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific DNA & RNA Oligonucleotides Market Size (2019-2030)
8.2 Asia-Pacific DNA & RNA Oligonucleotides Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region (2019-2024)
8.4 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America DNA & RNA Oligonucleotides Market Size (2019-2030)
9.2 Latin America DNA & RNA Oligonucleotides Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America DNA & RNA Oligonucleotides Market Size by Country (2019-2024)
9.4 Latin America DNA & RNA Oligonucleotides Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa DNA & RNA Oligonucleotides Market Size (2019-2030)
10.2 Middle East & Africa DNA & RNA Oligonucleotides Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2019-2024)
10.4 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Detail
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific DNA & RNA Oligonucleotides Introduction
11.1.4 Eurofins Scientific Revenue in DNA & RNA Oligonucleotides Business (2019-2024)
11.1.5 Eurofins Scientific Recent Development
11.2 Natera
11.2.1 Natera Company Detail
11.2.2 Natera Business Overview
11.2.3 Natera DNA & RNA Oligonucleotides Introduction
11.2.4 Natera Revenue in DNA & RNA Oligonucleotides Business (2019-2024)
11.2.5 Natera Recent Development
11.3 BGI
11.3.1 BGI Company Detail
11.3.2 BGI Business Overview
11.3.3 BGI DNA & RNA Oligonucleotides Introduction
11.3.4 BGI Revenue in DNA & RNA Oligonucleotides Business (2019-2024)
11.3.5 BGI Recent Development
11.4 Illumina
11.4.1 Illumina Company Detail
11.4.2 Illumina Business Overview
11.4.3 Illumina DNA & RNA Oligonucleotides Introduction
11.4.4 Illumina Revenue in DNA & RNA Oligonucleotides Business (2019-2024)
11.4.5 Illumina Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche DNA & RNA Oligonucleotides Introduction
11.5.4 Roche Revenue in DNA & RNA Oligonucleotides Business (2019-2024)
11.5.5 Roche Recent Development
11.6 LabCorp
11.6.1 LabCorp Company Detail
11.6.2 LabCorp Business Overview
11.6.3 LabCorp DNA & RNA Oligonucleotides Introduction
11.6.4 LabCorp Revenue in DNA & RNA Oligonucleotides Business (2019-2024)
11.6.5 LabCorp Recent Development
11.7 Berry Genomics
11.7.1 Berry Genomics Company Detail
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics DNA & RNA Oligonucleotides Introduction
11.7.4 Berry Genomics Revenue in DNA & RNA Oligonucleotides Business (2019-2024)
11.7.5 Berry Genomics Recent Development
11.8 Brooks Life Sciences
11.8.1 Brooks Life Sciences Company Detail
11.8.2 Brooks Life Sciences Business Overview
11.8.3 Brooks Life Sciences DNA & RNA Oligonucleotides Introduction
11.8.4 Brooks Life Sciences Revenue in DNA & RNA Oligonucleotides Business (2019-2024)
11.8.5 Brooks Life Sciences Recent Development
11.9 Macrogen
11.9.1 Macrogen Company Detail
11.9.2 Macrogen Business Overview
11.9.3 Macrogen DNA & RNA Oligonucleotides Introduction
11.9.4 Macrogen Revenue in DNA & RNA Oligonucleotides Business (2019-2024)
11.9.5 Macrogen Recent Development
11.10 Genotypic Technology
11.10.1 Genotypic Technology Company Detail
11.10.2 Genotypic Technology Business Overview
11.10.3 Genotypic Technology DNA & RNA Oligonucleotides Introduction
11.10.4 Genotypic Technology Revenue in DNA & RNA Oligonucleotides Business (2019-2024)
11.10.5 Genotypic Technology Recent Development
11.11 Dna Link
11.11.1 Dna Link Company Detail
11.11.2 Dna Link Business Overview
11.11.3 Dna Link DNA & RNA Oligonucleotides Introduction
11.11.4 Dna Link Revenue in DNA & RNA Oligonucleotides Business (2019-2024)
11.11.5 Dna Link Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global DNA & RNA Oligonucleotides Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of DNA Oligonucleotides
Table 3. Key Players of RNA Oligonucleotides
Table 4. Global DNA & RNA Oligonucleotides Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global DNA & RNA Oligonucleotides Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global DNA & RNA Oligonucleotides Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global DNA & RNA Oligonucleotides Market Share by Region (2019-2024)
Table 8. Global DNA & RNA Oligonucleotides Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global DNA & RNA Oligonucleotides Market Share by Region (2025-2030)
Table 10. DNA & RNA Oligonucleotides Market Trends
Table 11. DNA & RNA Oligonucleotides Market Drivers
Table 12. DNA & RNA Oligonucleotides Market Challenges
Table 13. DNA & RNA Oligonucleotides Market Restraints
Table 14. Global DNA & RNA Oligonucleotides Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global DNA & RNA Oligonucleotides Market Share by Players (2019-2024)
Table 16. Global Top DNA & RNA Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA & RNA Oligonucleotides as of 2023)
Table 17. Ranking of Global Top DNA & RNA Oligonucleotides Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by DNA & RNA Oligonucleotides Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players DNA & RNA Oligonucleotides Product Solution and Service
Table 21. Date of Enter into DNA & RNA Oligonucleotides Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global DNA & RNA Oligonucleotides Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global DNA & RNA Oligonucleotides Revenue Market Share by Type (2019-2024)
Table 25. Global DNA & RNA Oligonucleotides Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global DNA & RNA Oligonucleotides Revenue Market Share by Type (2025-2030)
Table 27. Global DNA & RNA Oligonucleotides Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global DNA & RNA Oligonucleotides Revenue Market Share by Application (2019-2024)
Table 29. Global DNA & RNA Oligonucleotides Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global DNA & RNA Oligonucleotides Revenue Market Share by Application (2025-2030)
Table 31. North America DNA & RNA Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America DNA & RNA Oligonucleotides Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America DNA & RNA Oligonucleotides Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe DNA & RNA Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe DNA & RNA Oligonucleotides Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe DNA & RNA Oligonucleotides Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific DNA & RNA Oligonucleotides Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America DNA & RNA Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America DNA & RNA Oligonucleotides Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America DNA & RNA Oligonucleotides Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa DNA & RNA Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2025-2030) & (US$ Million)
Table 46. Eurofins Scientific Company Detail
Table 47. Eurofins Scientific Business Overview
Table 48. Eurofins Scientific DNA & RNA Oligonucleotides Product
Table 49. Eurofins Scientific Revenue in DNA & RNA Oligonucleotides Business (2019-2024) & (US$ Million)
Table 50. Eurofins Scientific Recent Development
Table 51. Natera Company Detail
Table 52. Natera Business Overview
Table 53. Natera DNA & RNA Oligonucleotides Product
Table 54. Natera Revenue in DNA & RNA Oligonucleotides Business (2019-2024) & (US$ Million)
Table 55. Natera Recent Development
Table 56. BGI Company Detail
Table 57. BGI Business Overview
Table 58. BGI DNA & RNA Oligonucleotides Product
Table 59. BGI Revenue in DNA & RNA Oligonucleotides Business (2019-2024) & (US$ Million)
Table 60. BGI Recent Development
Table 61. Illumina Company Detail
Table 62. Illumina Business Overview
Table 63. Illumina DNA & RNA Oligonucleotides Product
Table 64. Illumina Revenue in DNA & RNA Oligonucleotides Business (2019-2024) & (US$ Million)
Table 65. Illumina Recent Development
Table 66. Roche Company Detail
Table 67. Roche Business Overview
Table 68. Roche DNA & RNA Oligonucleotides Product
Table 69. Roche Revenue in DNA & RNA Oligonucleotides Business (2019-2024) & (US$ Million)
Table 70. Roche Recent Development
Table 71. LabCorp Company Detail
Table 72. LabCorp Business Overview
Table 73. LabCorp DNA & RNA Oligonucleotides Product
Table 74. LabCorp Revenue in DNA & RNA Oligonucleotides Business (2019-2024) & (US$ Million)
Table 75. LabCorp Recent Development
Table 76. Berry Genomics Company Detail
Table 77. Berry Genomics Business Overview
Table 78. Berry Genomics DNA & RNA Oligonucleotides Product
Table 79. Berry Genomics Revenue in DNA & RNA Oligonucleotides Business (2019-2024) & (US$ Million)
Table 80. Berry Genomics Recent Development
Table 81. Brooks Life Sciences Company Detail
Table 82. Brooks Life Sciences Business Overview
Table 83. Brooks Life Sciences DNA & RNA Oligonucleotides Product
Table 84. Brooks Life Sciences Revenue in DNA & RNA Oligonucleotides Business (2019-2024) & (US$ Million)
Table 85. Brooks Life Sciences Recent Development
Table 86. Macrogen Company Detail
Table 87. Macrogen Business Overview
Table 88. Macrogen DNA & RNA Oligonucleotides Product
Table 89. Macrogen Revenue in DNA & RNA Oligonucleotides Business (2019-2024) & (US$ Million)
Table 90. Macrogen Recent Development
Table 91. Genotypic Technology Company Detail
Table 92. Genotypic Technology Business Overview
Table 93. Genotypic Technology DNA & RNA Oligonucleotides Product
Table 94. Genotypic Technology Revenue in DNA & RNA Oligonucleotides Business (2019-2024) & (US$ Million)
Table 95. Genotypic Technology Recent Development
Table 96. Dna Link Company Detail
Table 97. Dna Link Business Overview
Table 98. Dna Link DNA & RNA Oligonucleotides Product
Table 99. Dna Link Revenue in DNA & RNA Oligonucleotides Business (2019-2024) & (US$ Million)
Table 100. Dna Link Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global DNA & RNA Oligonucleotides Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global DNA & RNA Oligonucleotides Market Share by Type: 2023 VS 2030
Figure 3. DNA Oligonucleotides Features
Figure 4. RNA Oligonucleotides Features
Figure 5. Global DNA & RNA Oligonucleotides Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global DNA & RNA Oligonucleotides Market Share by Application: 2023 VS 2030
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Biopharma Companies Case Studies
Figure 9. Academic & Research Organizations Case Studies
Figure 10. Others Case Studies
Figure 11. DNA & RNA Oligonucleotides Report Years Considered
Figure 12. Global DNA & RNA Oligonucleotides Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global DNA & RNA Oligonucleotides Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global DNA & RNA Oligonucleotides Market Share by Region: 2023 VS 2030
Figure 15. Global DNA & RNA Oligonucleotides Market Share by Players in 2023
Figure 16. Global Top DNA & RNA Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA & RNA Oligonucleotides as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by DNA & RNA Oligonucleotides Revenue in 2023
Figure 18. North America DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America DNA & RNA Oligonucleotides Market Share by Country (2019-2030)
Figure 20. United States DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe DNA & RNA Oligonucleotides Market Share by Country (2019-2030)
Figure 24. Germany DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific DNA & RNA Oligonucleotides Market Share by Region (2019-2030)
Figure 32. China DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America DNA & RNA Oligonucleotides Market Share by Country (2019-2030)
Figure 40. Mexico DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa DNA & RNA Oligonucleotides Market Share by Country (2019-2030)
Figure 44. Turkey DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia DNA & RNA Oligonucleotides Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Eurofins Scientific Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2019-2024)
Figure 47. Natera Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2019-2024)
Figure 48. BGI Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2019-2024)
Figure 49. Illumina Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2019-2024)
Figure 50. Roche Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2019-2024)
Figure 51. LabCorp Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2019-2024)
Figure 52. Berry Genomics Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2019-2024)
Figure 53. Brooks Life Sciences Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2019-2024)
Figure 54. Macrogen Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2019-2024)
Figure 55. Genotypic Technology Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2019-2024)
Figure 56. Dna Link Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
